IBT
ICPT

International Biotechnology Trust’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

International Biotechnology Trust’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-441
Closed -$32K – 83
2022
Q2 		$32K Buy
+441
New +$7.06K 0.33% 55
2017
Q3 		– Sell
-11,155
Closed -$1.35M – 66
2017
Q2 		$1.35M Hold
11,155
– – 0.51% 45
2017
Q1 		$1.26M Sell
11,155
-18,400
-62% -$2.15M 0.48% 42
2016
Q4 		$3.21M Buy
+29,555
New +$3.52M 1.45% 17

Other funds holding ICPT

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

International Biotechnology Trust's ICPT Position: Q3 2022 in Review

International Biotechnology Trust sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2022, closing a stake of 441 shares — an estimated $32K sold.

International Biotechnology Trust first reported a position in ICPT in Q4 2016 and held it in 4 quarters. The position peaked at $3.21M in Q4 2016. 156 funds tracked by Wall St. Rank hold ICPT as of Q3 2022.

  • International Biotechnology Trust reported no remaining Intercept Pharmaceuticals, Inc. position as of Q3 2022 after selling out during the quarter.
  • International Biotechnology Trust sold 441 Intercept Pharmaceuticals, Inc. shares in Q3 2022, an estimated $32K.
  • International Biotechnology Trust first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2016 and held it in 4 quarters.
  • International Biotechnology Trust's Intercept Pharmaceuticals, Inc. position peaked at $3.21M in Q4 2016.
  • 156 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2022.

Based on International Biotechnology Trust's 13F filing for Q3 2022, filed 8 Nov 2022.